Invention Grant
US09216996B2 Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines and methods for treating viral infections
有权
取代的2,3,4,5,7,9,13,13a-八氢吡啶并[1'，2'：4,5]吡嗪并[2,1-b] [1,3]氧氮杂和治疗病毒感染的方法
![Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines and methods for treating viral infections](/docs/US/2015-12-22/US09216996B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines and methods for treating viral infections
- Patent Title (中): 取代的2,3,4,5,7,9,13,13a-八氢吡啶并[1'，2'：4,5]吡嗪并[2,1-b] [1,3]氧氮杂和治疗病毒感染的方法
-
Application No.: US14133858Application Date: 2013-12-19
-
Publication No.: US09216996B2Publication Date: 2015-12-22
- Inventor: Haolun Jin , Scott E. Lazerwith , Hyung-Jung Pyun
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Main IPC: A61K31/4985
- IPC: A61K31/4985 ; C07D241/38 ; C07D498/14 ; A61K31/537 ; C07D471/22 ; A61K31/529 ; A61K31/551 ; A61K31/498 ; C07D471/18 ; A61K45/06 ; C07D498/18
![Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines and methods for treating viral infections](/abs-image/US/2015/12/22/US09216996B2/abs.jpg.150x150.jpg)
Abstract:
Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, X, W, Y1, Y2, Z1, and Z4are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
Public/Granted literature
- US20140221356A1 POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE Public/Granted day:2014-08-07
Information query
IPC分类:
